hsa-miR-221

ncRNA information

ncRNA name

hsa-miR-221

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

Not available

Cancer information

Cancer name

Breast Cancer

Cancer site

Breast

Treatment information

Treatment type

Chemotherapy

Drug

Fulvestrant

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways.

Tissue resource

human breast cancer cell lines BT474

human breast cancer cell lines MCF7

human breast cancer fulvestrant-resistant cell lines MCF7-F

human breast cancer cell lines BT474

human breast cancer cell lines MCF7

human breast cancer fulvestrant-resistant cell lines MCF7-F

Experiment

qRT-PCR,Western blot


Institute

American Type Culture Collection

Country

USA

Continent

Amercia